Watch Demo

Greece Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Greece Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Greek lipid-modifying medicine sales are projected to decline from $360.14 million in 2021 to $260.58 million in 2026, an average year-on-year drop of 4.9%. Since 2013, the Greek market has decreased by 1.2% annually. In 2021, Greece ranked seventh, behind Australia ($360.14 million). Spain, Italy and Germany placed second, third and fourth, respectively.

Marketing Banner

Greece Lipid Modifying Drug Market Data and Forecasts

How much will Greece Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Greece
Forecast: Lipid Modifying Medicine Sales in Greece
Forecast: Lipid Modifying Medicine Sales in Greece
Forecast: Lipid Modifying Medicine Use in Greece
Forecast: Lipid Modifying Medicine Sales in Greece
More in Lipid Modifying Drug Industry for 2028